ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 96.1 | 85.7 | 66.7 |
| Other income | 2.1 | 1.4 | 2.0 |
| Total income | 98.2 | 87.1 | 68.7 |
| Profit before exceptional items & tax | 8.8 | 10.7 | 1.4 |
| Profit before tax | 8.8 | 10.7 | 1.4 |
| Net profit | 6.6 | 9.2 | 0.9 |
| Operating margin | 9.0% | 12.3% | 2.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +633.30% |
|---|---|
| Net profit, quarter on quarter | -28.30% |
| Revenue, year on year | +44.10% |
| Operating profit, year on year | +1216.70% |
| Operating profit, quarter on quarter | -28.00% |
BSE results filing, BSE: 544205. Figures extracted from the filing.
National Peroxide Ltd: key numbers
- Share price
- ₹544.10
- Market cap
- ₹312.7 Cr
- Revenue (annual)
- ₹289.7 Cr
- Net profit (annual)
- ₹5.82 Cr
- P/E (TTM)
- 18.1×Sector 35.5×
- Promoter holding
- 70.76%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from National Peroxide Ltd
All →National Peroxide Management Change
National Peroxide Limited appointed Mr. Amit Shah as General Manager – Sales & Marketing, effective 11 November 2026, as a senior management personnel change. The appointment was approved at a board meeting held the same day.
National Peroxide Q2 FY27 Results: Net Profit ₹0.9 Cr, Up 125.0% YoY
National Peroxide Ltd reported revenue from operations of ₹112 Cr (+64.0% YoY) and net profit of ₹0.9 Cr (+125.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.9 Cr · +125.0% YoY
National Peroxide Board Meeting Date
National Peroxide Limited has scheduled a board meeting for November 11, 2026. The board will consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026.
National Peroxide Other Announcement
National Peroxide Ltd has submitted its quarterly shareholding pattern filing for the period ended September 30, 2026. This is a routine regulatory disclosure under SEBI Regulation 31.
National Peroxide Management Change
National Peroxide Limited announced CEO Rajiv Arora's resignation, effective November 2, 2026. Vinay Divakar Jayade will succeed him as CEO and Whole-Time Director, effective November 3, 2026.
National Peroxide Annual General Meeting
National Peroxide Ltd held its 6th Annual General Meeting on September 29, 2026. Members considered resolutions including financial statement adoption and a final dividend declaration.